Improvement of the management of infants, children and adults with a molecular diagnosis of Enterovirus meningitis during two observational study periods
- PMID: 23874676
- PMCID: PMC3708915
- DOI: 10.1371/journal.pone.0068571
Improvement of the management of infants, children and adults with a molecular diagnosis of Enterovirus meningitis during two observational study periods
Abstract
Enteroviruses (EVs) are a major cause of aseptic meningitis, and RNA detection using molecular assay is the gold standard diagnostic test. The aim of this study was to assess the impact of an EV positive diagnosis on the clinical management of patients admitted for meningitis over the course of two observational study periods (2005 and 2008-09) in the same clinical departments. We further investigated in multivariate analysis various factors possibly associated with hospital length of stay (LOS) in all age groups (infants, children, and adults). The results showed an overall improvement in the management of patients (n = 142) between the study periods, resulting in a significantly shorter hospital LOS for adults and children, and a shorter duration of antibiotic use for adults and infants. In multivariate analysis, we observed that the time from molecular test results to discharge of patients and the median duration of antibiotic treatment were associated with an increase in LOS in all age groups. In addition, among adults, the turnaround time of the molecular assay was significantly correlated with LOS. The use of CT scan in children and hospital admission outside the peak of EV prevalence in infants tended to increase LOS. In conclusion, the shorter length of stay of patients with meningitis in this study was due to various factors including the rapidity of the EV molecular test (particularly in adults), greater physician responsiveness after a positive result (in adults and children), and greater experience on the part of physicians in handling EV meningitis, as evidenced by the shorter duration of antibiotic use in adults and infants.
Conflict of interest statement
References
-
- Dewan M, Zorc JJ, Hodinka RL, Shah SS (2010) Cerebrospinal fluid enterovirus testing in infants 56 days or younger. Arch Pediatr Adolesc Med 164: 824–830. - PubMed
-
- Peigue-Lafeuille H, Croquez N, Laurichesse H, Clavelou P, Aumaitre O, et al. (2002) Enterovirus meningitis in adults in 1999–2000 and evaluation of clinical management. J Med Virol 67: 47–53. - PubMed
-
- Archimbaud C, Chambon M, Bailly JL, Petit I, Henquell C, et al. (2009) Impact of rapid enterovirus molecular diagnosis on the management of infants, children, and adults with aseptic meningitis. J Med Virol 81: 42–48. - PubMed
-
- Huizing KM SC, Landstra AM, van Zwet AA, van Setten PA (2011) Rapid enterovirus molecular testing in cerebrospinal fluid reduces length of hospitalization and duration of antibiotic therapy in children with aseptic meningitis. Pediatr Infect Dis J 30: 1107–1109. - PubMed
-
- Chambon M, Archimbaud C, Bailly JL, Henquell C, Regagnon C, et al. (2001) Circulation of enteroviruses and persistence of meningitis cases in the winter of 1999–2000. J Med Virol 65: 340–347. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
